Home Tools

WP1066

Catalog No. T2156 CAS 857064-38-1

WP1066 is a inhibitor of JAK2 (IC50: 2.30 μM) and STAT3 (IC50: 2.43 μM) in HEL cells; shows activity to JAK2, STAT3/5, and ERK1/2, not JAK1 and JAK3. WP1066 has been used in trials studying the treatment of Melanoma, Brain Cancer, Solid Tumors, and Central Nervous System Neoplasms.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

WP1066, CAS 857064-38-1

Pack Size	Availability	Price/USD
5 mg	In stock	$ 44.00
10 mg	In stock	$ 74.00
25 mg	In stock	$ 133.00
50 mg	In stock	$ 225.00
100 mg	In stock	$ 315.00
500 mg	In stock	$ 768.00
1 mL * 10 mM (in DMSO)	In stock	$ 48.00

Bulk Inquiry

Select Batch

Purity: 99.73%

Purity: 99.07%

Biological Description

Chemical Properties

Storage & Solubility Information

Description	WP1066 is a inhibitor of JAK2 (IC50: 2.30 μM) and STAT3 (IC50: 2.43 μM) in HEL cells; shows activity to JAK2, STAT3/5, and ERK1/2, not JAK1 and JAK3. WP1066 has been used in trials studying the treatment of Melanoma, Brain Cancer, Solid Tumors, and Central Nervous System Neoplasms.
Targets&IC50	JAK2:2.3 μM, STAT3:2.43 μM
In vitro	WP1066 dose-dependently and significantly inhibits the growth of HEL cells harboring the JAK2 V617F mutation (IC20/IC50/IC80: 0.8/2.3/3.8 μM). In acute leukemia, HEL cells expressing the JAK2 V617F mutation, WP1066 (0.5-4.0 μM) inhibits the phosphorylation of JAK2, STAT3, STAT5, and ERK1/2, without affecting the phosphorylation of JAK1 and JAK3. WP1066 (0.5-3.0 μM) dose-dependently suppresses the proliferation of AML cells derived from patients, as well as OCIM2 and K562 AML cell lines. At concentrations of 0.5, 1.0, 2.0, 3.0, or 4.0 μM, WP1066 dose-dependently reduces the protein levels of JAK2 and pJAK2, along with the phosphorylation levels of STAT3, STAT5, and AKT in OCIM2 and K562 cells. WP1066 (1, 2, or 3 μM) activates procaspase-3 and cleaves PARP, inducing apoptosis in OCIM2 and K562 cells in a dose-dependent manner. WP1066 (2 μM) inhibits the proliferation of OCIM2 cells by inducing the accumulation of cells in the G0-G1 phase of the cell cycle. At 5 μM, WP1066 prevents STAT3 phosphorylation, and at 2.5 μM, it significantly inhibits the survival and proliferation of Caki-1 and 786-O renal cancer cells. WP1066 (5 μM) also suppresses the expression of HIF1α and HIF2α and the production of VEGF in Caki-1 and 786-O renal cancer cells.
In vivo	In Caki-1 xenografted mice, continuous administration of WP1066 (40 mg/kg/day, p.o.) for 19 days significantly inhibited tumor growth while concurrently reducing phosphorylated STAT3 immunostaining and lowering the length of CD34-positive blood vessels.
Cell Research	The 3, [4,5-dimethylthiazol-2-yl]-5-[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium (MTT) assay is done using an MTT-based cell proliferation/cytotoxicity assay system. Briefly, fresh low-density peripheral blood cells and various cell lines at the logarithmic phase of their growth are washed twice in RPMI 1640 containing 10% FCS and counted in a hemocytometer. Cell viability is assessed by the trypan blue (0.1%) staining method. Equal numbers of viable cells (5 × 104 per well) are incubated in a total volume of 100 μL of RPMI 1640 supplemented with 10% FCS alone or with WP1066 at increasing concentrations; the incubations are continued for up to 72 h in 96-well flat-bottomed plates at 37 °C in a humidified 5% CO2 atmosphere. Experiments for each condition are done in triplicate. After incubation, 20 μL of CellTiter96 One Solution Reagent are added to each well. The plates are then incubated for an additional 60 min at 37 °C in a humidified 5% CO2 atmosphere. Immediately after incubation, absorbance is read using a 96-well plate reader at a wavelength of 490 nm.(Only for Reference)

Molecular Weight	356.22
Formula	C17H14BrN3O
CAS No.	857064-38-1

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 66 mg/mL (185.3 mM)

Ethanol: < 1 mg/mL (insoluble or slightly soluble)

References and Literature

1. Verstovsek S, et al. Clin Cancer Res, 2008, (3), 788-796. 2. Hatiboglu MA, et al. Int J Cancer, 2012, 131(1), 8-17 3. Ferrajoli A, et al. Cancer Res, 2007, 67(23), 11291-11299. 4. Horiguchi A, et al. Br J Cancer, 2010, 102(11), 1592-1599. 5. Li M, Yu H. Identification of WP1066, an inhibitor of JAK2 and STAT3, as a Kv1. 3 potassium channel blocker[J]. . British Journal of Pharmacology. 2021

Citations

1. Li M, Yu H. Identification of WP1066, an inhibitor of JAK2 and STAT3, as a Kv1. 3 potassium channel blocker. British Journal of Pharmacology. 2021 Jul;178(13):2617-2631. doi: 10.1111/bph.15441. Epub 2021 May 20. 2. Ma X, Xu W, Jin X, et al.Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway.European Journal of Pharmacology.2023: 175529. 3. Hu Z, Sui Q, Jin X, et al.IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.Journal of Experimental & Clinical Cancer Research.2024, 43(1): 63.

Related compound libraries

This product is contained In the following compound libraries：

Drug Repurposing Compound Library Tyrosine Kinase Inhibitor Library Anti-Cancer Clinical Compound Library Anti-Cancer Active Compound Library Inhibitor Library Anti-Cancer Drug Library Bioactive Compounds Library Max Anti-Cancer Metabolism Compound Library Anti-Obesity Compound Library Anti-Prostate Cancer Compound Library

Related Products

Related compounds with same targets

Cysteamine hydrochloride Sodium salicylate Antineoplaston A10 AT9283 Targapremir-210 Metronidazole Dauricine Pinosylvin

Dose Conversion

You can also refer to dose conversion for different animals. More

In vivo Formulation Calculator (Clear solution)

Step One: Enter information below

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step Two: Enter the in vivo formulation

% DMSO+

% +

% Tween 80+

% ddH₂O

%DMSO+

Calculate Reset

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL)，Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation：Take μL DMSO master liquid, next add μL PEG300， mix and clarify, next add μL Tween 80，mix and clarify, next add μL ddH₂O, mix and clarify.

Note:

Be sure to add the solvent(s) in order. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Calculator

Molarity Calculator

Dilution Calculator

Reconstitution Calculation

Molecular Weight Calculator

Mass

Concentration

Volume

Molecular Weight

Molarity Calculator allows you to calculate the

Mass of a compound required to prepare a solution of known volume and concentration
Volume of solution required to dissolve a compound of known mass to a desired concentration
Concentration of a solution resulting from a known mass of compound in a specific volume

See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

Concentration (Start)

Volume (Start)

Concentration (End)

Volume (End)

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Molecule Formula

Molecular Weight g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

WP1066 857064-38-1 Angiogenesis Apoptosis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK STAT WP 1066 inhibit Inhibitor Janus kinase WP-1066 inhibitor

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.